TMDI News and Press, Titan Medical Inc. From 04/07/21

Gainers: Odonate Therapeutics (ODT) +34%, Ocugen (OCGN) +24%, Titan Medical (TMDI) +15%, Frequency Therapeutics (FREQ) +14, 9 Meters Biopharma (NMTR) +10%%.Losers: FibroGen (FGEN) -39%, Homology Medicines (FIXX) -18%, Galectin Therap...

Today pre-market analyst action includes downgrades on Fibrogen and ACADIA due to recent FDA decisions on companies’ new drug applications.Fibrogen slips as analysts weigh in on safety updateFibrogen (FGEN) shares plunged in the post-market yesterday in reaction to clarification m...

SOS (SOS) +36%.Titan Medical (TMDI) +25%.CBAK Energy Technology (CBAT) +21%.Altimeter Growth (AGCUU) +18%.CA Healthcare Acquisition (CAHCU) +16%.TransMedics (TMDX) +16%. as FDA Advisory Panel has issued a favorable vote in support of approval of the OCS Heart System.Altimeter Growth (AGC...

April is Getting Off to a Great Start For These 5 Biotech Stocks With only six days behind us in April so far, biotech penny stocks continue to lead the charge. Since they’re so cheap (stocks under $5, by definition), traders are on the hunt for the next breakout name. The obviou...

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that David McNally, President, CEO and Chairman...

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that, David McNally, President, CEO and Chairma...

Titan Medical ([[TMDI]] +13.2%) has issued a corporate update ahead of its presentation at H.C. Wainwright Global Life Sciences Conference scheduled for today.The company reported ~$65.5M of pro forma cash and cash equivalents as of January 31, 2021, up from $25.5M as of 2020 year-e...

Large market opportunity, strong corporate foundation, innovative robotic-assisted technology Clinical studies expected to commence in 2022 Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company f...

Not for Distribution to United States News Wire Services or for Dissemination in the United States Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the d...

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the release of its annual financial results for...